# VirtualScopics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virtualscopics

- Industry: Biotechnology
- Headquarters: Rochester, US
- Website: www.virtualscopics.com
- Total disclosed funding: $3.8M
- Latest round: Series C (Feb 10, 2003)
- Investors on record: 2

## About

VirtualScopics delivers innovative imaging solutions for clinical trials, enhancing the accuracy of data analysis through advanced imaging technology. Its services support the pharmaceutical and biotechnology industries in drug development.Founded in 2000 in Rochester, US, VirtualScopics specializes in imaging analytics for clinical trials. The company has successfully completed 5 deals, with the most recent deal occurring in January 2005, when it completed a Series C funding round of USD 3.00 mn. VirtualScopics has not undergone significant pivots in business strategy since its inception.VirtualScopics offers a range of imaging services aimed at clinical research and drug development. Their primary offerings include advanced imaging analytics solutions that help pharmaceutical and biotechnology companies in assessing the effectiveness of treatments through precise data interpretation. The company serves a global client base with a focus on enhancing the efficiency of clinical trials and improving patient outcomes through superior imaging technology.In the most recent financial year 2015, VirtualScopics reported a revenue of USD 12,716,884 with an EBITDA of USD -561,120. The revenue is primarily generated from contracts with pharmaceutical companies for imaging services related to clinical trials.Looking ahead, VirtualScopics aims to expand its service offerings and explore new markets. The recent funding round in January 2005 will be utilized to enhance their imaging technologies and streamline operations. The company plans to introduce new imaging solutions tailored for the evolving needs of clinical research, focusing on the North American and European markets by 2025.

## Funding rounds

- Series C, Feb 10, 2003, $3.8M — Trillium Group, GE Healthcare

## Investors

- Trillium Group (https://capitalatlas.ai/funds/trillium-group) — Series C
- GE Healthcare — Series C